Search by Drug Name or NDC

    NDC 00078-0456-35 Trileptal 150 mg/1 Details

    Trileptal 150 mg/1

    Trileptal is a ORAL TABLET, FILM COATED in the HUMAN PRESCRIPTION DRUG category. It is labeled and distributed by Novartis Pharmaceuticals Corporation. The primary component is OXCARBAZEPINE.

    Product Information

    NDC 00078-0456
    Product ID 0078-0456_2201beee-4887-43fa-9343-ac93936b0b90
    Associated GPIs 72600046000310
    GCN Sequence Number 044336
    GCN Sequence Number Description oxcarbazepine TABLET 150 MG ORAL
    HIC3 H4B
    HIC3 Description ANTICONVULSANTS
    GCN 21724
    HICL Sequence Number 011735
    HICL Sequence Number Description OXCARBAZEPINE
    Brand/Generic Brand
    Proprietary Name Trileptal
    Proprietary Name Suffix n/a
    Non-Proprietary Name oxcarbazepine
    Product Type HUMAN PRESCRIPTION DRUG
    Dosage Form TABLET, FILM COATED
    Route ORAL
    Active Ingredient Strength 150
    Active Ingredient Units mg/1
    Substance Name OXCARBAZEPINE
    Labeler Name Novartis Pharmaceuticals Corporation
    Pharmaceutical Class Anti-epileptic Agent [EPC], Decreased Central Nervous System Disorganized Electrical Activity [PE]
    DEA Schedule n/a
    Marketing Category NDA
    Application Number NDA021014
    Listing Certified Through 2024-12-31

    Package

    NDC 00078-0456-35 (00078045635)

    NDC Package Code 0078-0456-35
    Billing NDC 00078045635
    Package 100 BLISTER PACK in 1 BOX, UNIT-DOSE (0078-0456-35) / 1 TABLET, FILM COATED in 1 BLISTER PACK (0078-0456-61)
    Marketing Start Date 2000-01-30
    NDC Exclude Flag N
    Pricing Information N/A